cytarabine has been researched along with Ambulation Disorders, Neurologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hem, S; Kohan, D; Otero, V; Pappolla, A; Rugiero, M; Sosa-Albacete, F; Zurru-Ganen, MC | 1 |
| Abe, A; Hayasaka, K; Kawakami, K; Kawano, Y; Kumamoto, T; Nishikawa, T; Okamoto, Y; Tonooka, S | 1 |
| Abrey, LE; DeAngelis, LM; Lai, R; Rosenblum, MK | 1 |
1 review(s) available for cytarabine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cranial Irradiation; Cytarabine; Dementia; Dementia, Vascular; Demyelinating Diseases; Disease Progression; Doxorubicin; Epilepsy, Complex Partial; Etoposide; Eye Neoplasms; Fatal Outcome; Female; Gait Disorders, Neurologic; Humans; Immunocompetence; Intracranial Arteriosclerosis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Radiation Injuries; Retrospective Studies; Survival Analysis; Thiotepa; Vincristine | 2004 |
2 other study(ies) available for cytarabine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
[Primary neurolymphomatosis in the cauda equina as the initial symptom of human immunodeficiency virus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cauda Equina; Cytarabine; Gait Disorders, Neurologic; Humans; Kidney Neoplasms; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Neurolymphomatosis; Rituximab | 2019 |
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Charcot-Marie-Tooth Disease; Contraindications; Cytarabine; Daunorubicin; Etoposide; Gait Disorders, Neurologic; Humans; Male; Mercaptopurine; Methotrexate; Muscle Weakness; Neural Conduction; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 2008 |